… Retinal vein occlusions have an age- and sex-standardized prevalence of … vein occlusion
is recognized as an important cause of blindness and the diagnostic approaches and treatment …

… 61 Thach AB, Yau L, Hoang C, Tuomi L: Time to clinically significant visual acuity gains after
ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials. Ophthalmology …

… edema due to branch retinal vein occlusion and reduces the overall ischemic … vein occlusion
but does not improve visual acuity better than observation. Numerous surgical treatments …

… Intravitreal anti-VEGF drugs represent the latest, safe and effective therapeutic option for RVO.
In … Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab the …

… with branch retinal vein occlusion treated with ranibizumab have an excellent long-term
outcome. a Mean best-corrected visual acuity (BCVA) in Early Treatment Diabetic Retinopathy …

… Given the complex physiopathology of RVO, most of the latest therapeutic strategies focus
… Hyperbaric oxygen treatment has been proven to be beneficial for treating various ischemic …

… Systemic anticoagulants (such as oral aspirin, subcutaneous heparin, or intravenous
thrombolysis) have not been shown to be an effective treatment for vein occlusions. …

… We also used the latest guidance from the UK Royal College of Ophthalmologists on the …
at the value of starting such treatment after retinal vein occlusion has taken place, the Royal …

… In conclusion, it is evident that the complications of laser-induced chorioretinal venous
anastomosis for treatment of nonischemic CRVO heavily outweigh any dubious benefits, and that …

… Similarly to CRVO treatment, intravitreal drug administration is the latest breakthrough…
treating edema secondary to BRVO of short duration has a better effect than delaying the treatment…